Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

LFSC

F/m Emerald Life Sciences Innovation ETF

Nov 28 • 01:30PM ET

37.91

+0.30 0.79 %

Financial • Exchange Traded Fund • USA • NASD

Held by: NMBL

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	46.51%	Total Holdings	36	Perf Week	12.28%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	AUM	91.32M	Perf Month	19.67%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	NAV/sh		Perf Quarter	36.02%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		52W High	37.78 0.34%	Perf Half Y	62.07%
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		52W Low	18.78 101.86%	Perf YTD	62.07%
Active/Passive		Quant Type		Tags	medical	Flows% 1M	2.37%	Volatility	2.46% 1.89%	Perf Year	44.12%
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	4.53%	ATR (14)	0.82	Perf 3Y	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	11.50%	RSI (14)	76.67	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.29	Perf 10Y	-
Expense	0.54%	Growth/Value		SMA20	11.24%	Flows% 3Y		Rel Volume	0.51	Prev Close	37.61
Inverse/Leveraged		Market Cap		SMA50	19.26%	Flows% 5Y		Avg Volume	3.26K	Price	37.91
IPO	Oct 31, 2024	Option/Short	No / Yes	SMA200	44.31%	Trades		Volume	1,650	Change	0.79%

Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

Black Swan Sale

50% Off Elite

LFSC

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience